InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

BA

Balcom Alexandra

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€5m

▼ Sales (16 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

16

T+90 hit rate

0%

T+90 mean return

-9.1%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the detailed record of transactions filed by Balcom Alexandra. Insider active across 1 company, notably Nuvalent, Inc.. Aggregated, 44 disclosures have been published. Breakdown: 0 buy · 16 sells. Total volume traded: €5.1m. History available since 31 July 2023. The latest transaction was disclosed on 15 July 2026 (U). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Balcom Alexandra

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Nuvalent, Inc. (US)

Declarations44 total

●

Balcom Alexandra

Chief Financial OfficerExecutives15 Jul 2026Nuvalent, Inc.

44,433 shares@ US$124.00Class A Common StockSEC:0001193125-26-305094:0

●

Balcom Alexandra

Chief Financial OfficerExecutives15 Jul 2026Nuvalent, Inc.

41,100 sharesClass A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305094:1

◆

Balcom Alexandra

Chief Financial OfficerExecutives15 Jul 2026Nuvalent, Inc.

14,350 shares0Class A Common Stock - Performance Stock UnitsSEC:0001193125-26-305094:2

●

Balcom Alexandra

Chief Financial OfficerExecutives15 Jul 2026Nuvalent, Inc.

14,350 sharesClass A Common Stock - Performance Stock UnitsSEC:0001193125-26-305094:3

◇

Balcom Alexandra

Chief Financial OfficerExecutives1 Jul 2026Nuvalent, Inc.

$37,09621SEC ↗

5,384 shares@ US$6.890.0004% mcap0.6% of flowClass A Common StockSEC:0001862147-26-000009:0

◇

Balcom Alexandra

Chief Financial OfficerExecutives1 Jul 2026Nuvalent, Inc.

$114,45121SEC ↗

6,046 shares@ US$18.930.0012% mcap2.0% of flowClass A Common StockSEC:0001862147-26-000009:1

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jul 2026Nuvalent, Inc.

11,430 shares@ US$123.580.015% mcap24.1% of flowClass A Common StockSEC:0001862147-26-000009:2

◇

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$78,75322SEC ↗

11,430 shares@ US$6.890.0008% mcap1.8% of flowClass A Common StockSEC:0001862147-26-000007:0

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$91,07522SEC ↗

960 shares@ US$94.870.0010% mcap2.1% of flowClass A Common StockSEC:0001862147-26-000007:1

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$208,29822SEC ↗

2,170 shares@ US$95.990.0022% mcap4.7% of flowClass A Common StockSEC:0001862147-26-000007:2

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$87,91222SEC ↗

900 shares@ US$97.680.0009% mcap2.0% of flowClass A Common StockSEC:0001862147-26-000007:3

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$118,28422SEC ↗

1,200 shares@ US$98.570.0013% mcap2.7% of flowClass A Common StockSEC:0001862147-26-000007:4

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$312,86123SEC ↗

3,133 shares@ US$99.860.0033% mcap7.1% of flowClass A Common StockSEC:0001862147-26-000007:5

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$260,48223SEC ↗

2,588 shares@ US$100.650.0028% mcap5.9% of flowClass A Common StockSEC:0001862147-26-000007:6

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$28,39922SEC ↗

279 shares@ US$101.790.0003% mcap0.6% of flowClass A Common StockSEC:0001862147-26-000007:7

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Jun 2026Nuvalent, Inc.

$20,76822SEC ↗

200 shares@ US$103.840.0002% mcap0.5% of flowClass A Common StockSEC:0001862147-26-000007:8

◇

Balcom Alexandra

Chief Financial OfficerExecutives1 Apr 2026Nuvalent, Inc.

$12,34419SEC ↗

11,430 shares@ US$1.080.2% of flowClass A Common StockSEC:0001862147-26-000004:0

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Apr 2026Nuvalent, Inc.

$369,95820SEC ↗

3,544 shares@ US$104.395.1% of flowClass A Common StockSEC:0001862147-26-000004:1

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Apr 2026Nuvalent, Inc.

$570,41020SEC ↗

5,417 shares@ US$105.307.9% of flowClass A Common StockSEC:0001862147-26-000004:2

▼

Balcom Alexandra

Chief Financial OfficerExecutives1 Apr 2026Nuvalent, Inc.

$262,15819SEC ↗

2,469 shares@ US$106.183.6% of flowClass A Common StockSEC:0001862147-26-000004:3

◇

Balcom Alexandra

Chief Financial OfficerExecutives24 Mar 2026Nuvalent, Inc.

$12,34419SEC ↗

11,430 shares@ US$1.080.2% of flowClass A Common StockSEC:0001862147-26-000002:0

▼

Balcom Alexandra

Chief Financial OfficerExecutives5 Jan 2026Nuvalent, Inc.

$83,66837SEC ↗

871 shares@ US$96.060.9% of flowClass A Common StockSEC:0001193125-26-006569:0

◇

Balcom Alexandra

Chief Financial OfficerExecutives22 Dec 2025Nuvalent, Inc.

$37,26019SEC ↗

34,500 shares@ US$1.080.8% of flowClass A Common StockSEC:0001193125-25-331014:0

▼

Balcom Alexandra

Chief Financial OfficerExecutives8 Dec 2025Nuvalent, Inc.

$770,40535SEC ↗

6,984 shares@ US$110.318.8% of flowClass A Common StockSEC:0001193125-25-314301:0

◇

Balcom Alexandra

Chief Financial OfficerExecutives17 Nov 2025Nuvalent, Inc.

$47,36919SEC ↗

6,875 shares@ US$6.890.6% of flowClass A Common StockSEC:0001193125-25-288317:0

25 of 44 declarations

About Balcom Alexandra

Balcom Alexandra is a declarant who has made 23 filings in total. In the most recent filings, they sold a total of 2084972 euros between August 1, 2023, and June 3, 2026. Notable transactions include a sale of 625526.73 euros and another of 488168.29 euros, both dated August 1, 2023.